European Market Report for Lancet and Lancing Devices 2016 - MedCore

European Market Report for Lancet and Lancing Devices 2016 - MedCore

The value of the lancet and lancing device increased in 2015 and modest growth is expected to continue over the forecast period, driven by increasing unit sales and limited by ASP erosion. Unit sales growth will be driven by the increasing patient population and as a result, increasing number of diabetics that are testing their blood glucose levels. However, unit sales growth will be moderated by the continuing trend of manufacturers giving away complimentary lancet and lancing devices to patients, as well as lancet reuse among the diabetic population. ASP erosion will also be driven by the existence of complimentary devices and by the growth of low-price competitors in the lancet and lacing device market. Typically, lancets are sold in packs of 100 or 200, but some are sold in packs of 25, 102, 204 and other combinations. For this reason, ASP is quoted on a per lancet basis.

A lancet is a small needle with a plastic or rubber coating that fits into the top of a lancing device. Lancing devices are pen-like instruments which are used in conjunction with a lancet to draw blood to be applied to a glucose strip. Many lancets come as a component of blood glucose monitoring kits, and can be adjusted for injection depth. Reusable lancets are not as effective as they are more dull and painful and increase the risk of infection.


EXECUTIVE SUMMARY
EUROPEAN MARKET FOR DIABETES MONITORING, TREATMENT AND DRUG DELIVERY
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 INTRODUCTION
2.1.1 Types of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
2.1.4 Signs and Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
COUNTRY PROFILES
3.1 INTRODUCTION
3.1.1.1 Population
3.1.1.2 GDP Per Capita
3.1.1.3 Units
3.2 GERMANY
3.3 FRANCE
3.4 UNITED KINGDOM
3.5 ITALY
3.6 SPAIN
3.7 BENELUX
3.8 SCANDINAVIA
3.9 AUSTRIA
3.10 SWITZERLAND
3.11 PORTUGAL
LANCET AND LANCING DEVICE MARKET
4.1 INTRODUCTION
4.2 MARKET ANALYSIS AND FORECAST
4.3 DRIVERS AND LIMITERS
4.3.1 Market Drivers
4.3.2 Market Limiters
4.4 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
List of Charts
Chart 1 1: Diabetes Diagnosis, Treatment and Drug Delivery, Europe, 2012 – 2022
Chart 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Market Overview, Europe, 2012 & 2022
Chart 3 1: Country Profile, Germany, 2015
Chart 3 2: Country Profile, France, 2015
Chart 3 3: Country Profile, United Kingdom, 2015
Chart 3 4: Country Profile, Italy, 2015
Chart 3 5: Country Profile, Spain, 2015
Chart 3 6: Country Profile, Benelux, 2015
Chart 3 7: Country Profile, Scandinavia, 2015
Chart 3 8: Country Profile, Austria, 2015
Chart 3 9: Country Profile, Switzerland, 2015
Chart 3 10: Country Profile, Portugal, 2015
Chart 4 1: Total Lancet and Lancing Device Market, Europe, 2012 – 2022
Chart 4 2: Leading Competitors, Lancet and Lancing Device Market, Europe, 2015
List of Figures
Figure 1 1: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2)
Figure 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2)
Figure 1 3: Companies Researched in this Report, Europe, 2015
Figure 1 4: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (1 of 2)
Figure 1 5: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (2 of 2)
Figure 1 6: Recent Events in the Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2016
Figure 2 1: Major Types of Diabetes and Related Pathologies, Europe, 2015
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, Europe, 2015
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, Europe, 2015
Figure 4 1: Total Lancet and Lancing Device Market, Europe, 2012 – 2022 (€ and US$)
Figure 4 2: Units Sold (Millions) by Country, Total Lancet and Lancing Device Market, Europe, 2012 – 2022
Figure 4 3: Average Selling Price by Country, Total Lancet and Lancing Device Market, Europe, 2012 – 2022 (€)
Figure 4 4: Average Selling Price by Country, Total Lancet and Lancing Device Market, Europe, 2012 – 2022 (US$)
Figure 4 5: Market Value by Country, Total Lancet and Lancing Device Market, Europe, 2012 – 2022 (€M)
Figure 4 6: Market Value by Country, Total Lancet and Lancing Device Market, Europe, 2012 – 2022 (US$M)
Figure 4 7: Drivers and Limiters, Lancet and Lancing Device Market, Europe, 2015
Figure 4 8: Leading Competitors, Lancet and Lancing Device Market, Europe, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook